Clinical and echocardiographic correlates of plasma B-type natriuretic peptide levels in patients with aortic valve stenosis and normal left ventricular ejection fraction

Echocardiography

Volumn 28, Issue 7, 2011, Pages 695-702

  Maréchaux, Sylvestre ^a,b   Hattabi, Mehdi ^b   Juthier, Francis ^b   Neicu, Dan Valentin ^b   Richardson, Marjorie ^b   Carpentier, Emilie ^b   Bouabdallaoui, Nadia ^b   Delelis, François ^b   Banfi, Carlo ^b   Breyne, Joke ^b   Jude, Brigitte ^b   Asseman, Philippe ^b   Vincentelli, André ^b   Le Tourneau, Thierry ^b   Graux, Pierre ^a   Pibarot, Philippe ^c   Ennezat, Pierre Vladimir ^b  

^a UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^b UNIV LILLE   (France)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

aortic stenosis; BNP; echocardiography

Indexed keywords

NATRIURETIC PEPTIDE RECEPTOR B;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE STENOSIS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY PULSE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE MASS; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SINGLE BLIND PROCEDURE;

AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; REGRESSION ANALYSIS; RISK FACTORS; STROKE VOLUME;

EID: 80051875705     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2011.01418.x     Document Type: Article

References (34)

1. Freeman RV, Otto CM,: Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111: 3316-3326. (Pubitemid 40875006)
2. Vahanian A, Baumgartner H, Bax J, et al,: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268. (Pubitemid 46276943)
3. Van Pelt NC, Stewart RA, Legget ME, et al,: Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis. Heart 2007; 93: 732-738. (Pubitemid 46808278)
4. Yamamoto K, Burnett JC, Jr,., Jougasaki M, et al,: Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994. (Pubitemid 26415815)
5. Logeart D, Gambert A, Beyne P, et al,: [Brain natriuretic peptide (BNP) in coronary insufficiency: Relationship with left ventricular filling and exercise tolerance]. Ann Cardiol Angeiol (Paris) 1999; 48: 523-528.
6. Yamamoto K, Burnett JC, Jr,., Bermudez EA, et al,: Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 2000; 6: 194-200.
7. Cataliotti A, Malatino LS, Jougasaki M, et al,: Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001; 76: 1111-1119. (Pubitemid 33032388)
8. Grewal J, McKelvie R, Lonn E, et al,: BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008; 10: 252-259. (Pubitemid 351343862)
9. May HT, Horne BD, Levy WC, et al,: Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide. Am J Cardiol 2007; 100: 697-700. (Pubitemid 47223146)
10. Lim P, Monin JL, Monchi M, et al,: Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: Role of B-type natriuretic peptide. Eur Heart J 2004; 25: 2048-2053. (Pubitemid 39486025)
11. Monin JL, Lancellotti P, Monchi M, et al,: Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation 2009; 120: 69-75.
12. Bergler-Klein J, Mundigler G, Pibarot P, et al,: B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: Relationship to hemodynamics and clinical outcome: Results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 2007; 115: 2848-2855. (Pubitemid 46869672)
13. Detaint D, Messika-Zeitoun D, Avierinos JF, et al,: B-type natriuretic peptide in organic mitral regurgitation: Determinants and impact on outcome. Circulation 2005; 111: 2391-2397. (Pubitemid 40647075)
14. Bergler-Klein J, Klaar U, Heger M, et al,: Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109: 2302-2308. (Pubitemid 38678520)
15. Wians FH, Jr,., Wilson BA, Grant A, et al,: Evaluation of the analytical performance characteristics of the Bayer ACS:180 B-type natriuretic peptide (BNP) assay. Clin Chim Acta 2005; 353: 147-155. (Pubitemid 40215442)
16. Lang RM, Bierig M, Devereux RB, et al,: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463. (Pubitemid 41821197)
17. Ommen SR, Nishimura RA, Appleton CP, et al,: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler- catheterization study. Circulation 2000; 102: 1788-1794.
18. Marechaux S, Pincon C, Le Tourneau T, et al,: Cardiac correlates of exercise induced pulmonary hypertension in patients with chronic heart failure due to left ventricular systolic dysfunction. Echocardiography 2008; 25: 386-393. (Pubitemid 351432681)
19. de Monchy CC, Lepage L, Boutron I, et al,: Usefulness of the right parasternal view and non-imaging continuous-wave Doppler transducer for the evaluation of the severity of aortic stenosis in the modern area. Eur J Echocardiogr 2009; 10: 420-424.
20. Adegunsoye A, Mundkur M, Nanda NC, et al,: Echocardiographic Evaluation of Calcific Aortic Stenosis in the Older Adult. Echocardiography 2011.
21. Baumgartner H, Hung J, Bermejo J, et al,: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009; 10: 1-25.
22. Das P, Rimington H, Chambers J,: Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005; 26: 1309-1313. (Pubitemid 41435462)
23. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al,: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982. (Pubitemid 34994995)
24. Das SR, Drazner MH, Dries DL, et al,: Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation 2005; 112: 2163-2168. (Pubitemid 41475811)
25. Orlowska-Baranowska E, Baranowski R, Greszata L, et al,: Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis. J Heart Valve Dis 2008; 17: 598-605.
26. Galema TW, Yap SC, Geleijnse ML, et al,: Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis. J Am Soc Echocardiogr 2008; 21: 257-261. (Pubitemid 351313855)
27. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al,: Severe pulmonary hypertension in patients with severe aortic valve stenosis: Clinical profile and prognostic implications. J Am Coll Cardiol 2002; 40: 789-795. (Pubitemid 34925628)
28. Vanderheyden M, Goethals M, Verstreken S, et al,: Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004; 44: 2349-2354. (Pubitemid 39647609)
29. Marechaux S, Carpentier E, Six-Carpentier M, et al,: Impact of valvuloarterial impedance on left ventricular longitudinal deformation in patients with aortic valve stenosis and preserved ejection fraction. Archives of Cardiovascular Diseases 2010; 103: 227-235.
30. Beaver TA, Steiner J, Sullivan CD, et al,: Two-Dimensional Longitudinal Strain in Patients with Aortic Stenosis Can Be Reliably Acquired at the Bedside without Additional Benefit of Offline Analysis. Echocardiography 2010.
31. Wu WC, Ireland LA, Sadaniantz A,: Evaluation of aortic valve disorders using stress echocardiography. Echocardiography 2004; 21: 459-466. (Pubitemid 38830040)
32. Lancellotti P, Lebois F, Simon M, et al,: Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005; 112 (9 Suppl): I377-4382.
33. Marechaux S, Ennezat PV, LeJemtel TH, et al,: Left ventricular response to exercise in aortic stenosis: An exercise echocardiographic study. Echocardiography 2007; 24: 955-959. (Pubitemid 47485651)
34. Marechaux S, Hachicha Z, Bellouin A, et al,: Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010; 31: 1390-1397.